Jeong H, Jeong JH, Kim JE, Ahn JH, et al. Final results of the randomized phase 2 LEO trial and bone protective effects of
everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic
breast cancer. Int J Cancer 2021 Apr 27. doi: 10.1002/ijc.33613.
PMID: 33905134